These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3766056)

  • 1. [Blood volume and urinary sodium, potassium and uric acid in cirrhosis. Evidence of the hypersensitivity of the nephron to aldosterone].
    Decaux G; Hanson B; Cauchie P; Bosson D; Unger J
    Acta Gastroenterol Belg; 1986; 49(1):13-9. PubMed ID: 3766056
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between aldosterone and sodium, potassium, and uric acid clearance in cirrhosis with and without ascites.
    Decaux G; Hanson B; Cauchie P; Bosson D; Unger J
    Nephron; 1986; 44(3):226-9. PubMed ID: 3785485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Depletive treatment of uncompensated liver cirrhosis with high doses of spirolactone only].
    Zotti S; Dagnini G; Abrahamsohn C; de Nadai Frank A; Sandri R
    Minerva Med; 1977 Feb; 68(7):431-7. PubMed ID: 320504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma uric acid concentration related to the urinary excretion of aldosterone and of electrolytes in normal subjects.
    Ramsay LE; Auty RM; Horth CE; Levine D; Shelton JR; Branch RA
    Clin Sci Mol Med; 1975 Dec; 49(6):613-6. PubMed ID: 1204292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the renin-aldosterone system in decompensated cirrhosis.
    Epstein M; Levinson R; Sancho J; Haber E; Re R
    Circ Res; 1977 Dec; 41(6):818-29. PubMed ID: 923033
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
    Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
    Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion.
    Decaux G; Prospert F; Namias B; Schlesser M; Soupart A
    Gut; 1992 Aug; 33(8):1105-8. PubMed ID: 1398236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypouricemia in cirrhosis reflects hemodynamic alterations.
    Decaux G; Mols P; Naeije R; Reding P
    Metabolism; 1984 Aug; 33(8):750-3. PubMed ID: 6748949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia induced by fructose load in liver cirrhosis.
    Budillon G; Citarella C; Loguercio C; Nardone G; Sicolo P; Del Vecchio Blanco C
    Ital J Gastroenterol; 1992 Sep; 24(7):373-7. PubMed ID: 1392016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Excretion of uric aid, sodium, and potassium in preeclampsia patients and its behavior in acute hyperglycemia-hyperinsulinemia].
    Martínez-Abundis E; González-Ortiz M; Grover-Páez F; Vera-Hernández A
    Ginecol Obstet Mex; 1999 Dec; 67():590-4. PubMed ID: 10692810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of deranged sodium and water homeostasis in decompensated cirrhosis.
    Epstein M; Pins DS; Schneider N; Levinson R
    J Lab Clin Med; 1976 May; 87(5):822-39. PubMed ID: 1270890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
    Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
    J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tubular acidosis in cirrhosis. A determinant of susceptibility to recurrent hepatic precoma.
    Shear L; Bonkowsky HL; Gabuzda GJ
    N Engl J Med; 1969 Jan; 280(1):1-7. PubMed ID: 5761704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Obervations on the clinical use of ethacrynic acid].
    Stirati G; Massini R; Cinotti GA
    Minerva Nefrol; 1969; 16(1):77-83. PubMed ID: 5791717
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium retention and ascites formation in a cholestatic mice model: role of aldosterone and mineralocorticoid receptor?
    Ackermann D; Mordasini D; Cheval L; Imbert-Teboul M; Vogt B; Doucet A
    Hepatology; 2007 Jul; 46(1):173-9. PubMed ID: 17596887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial natriuretic factor in liver cirrhosis. The effect of volume loading].
    Tesar V; Horký K; Petrtýl J; Kozáková M; Gregorová I; Brodanová M; Kordac V; Jirsa M
    Cas Lek Cesk; 1988 Dec; 127(49):1515-21. PubMed ID: 2975531
    [No Abstract]   [Full Text] [Related]  

  • 20. Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?
    Cholongitas E; Karatapanis S; Nakouti T; Birtsou C; Skorda L; Kouvelis I; Papastergiou V; Papachrysos N; Goulis J; Akriviadis E
    Liver Int; 2012 Jan; 32(1):172-3. PubMed ID: 22098704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.